Connect® MDS/AML Disease Registry

Connect Myeloid: The Myelofibrosis (MF), Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry

  • Clinical Trial Information

    Trial Contact: Britton, David ; Rodriguez Saavedra, Carlis M

    Trial Phone: 321.841.2684 ; 321.841.6764

  • IRB No: 13.144.09

    Protocol Abbrev: Connect MDS

    Principal Investigator: Daniel Ari Landau, MD

    Age Group: Adult

    Secondary Protocol No: AZA-MDS-006 ID: NCT01688011

  • Objective

    The purpose of the registry is to provide insights into treatment regimens of patients with newly diagnosed MDS or AML

  • Key Eligibility

    AML or MDS newly diagnosed